申请人:Takeda Pharmaceutical Company Limited
公开号:US10100018B2
公开(公告)日:2018-10-16
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof,
wherein R1, X, m, R2, Y, R3, Z, n, R4, A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供了式 (I) 化合物及其药学上可接受的盐类、
其中 R1、X、m、R2、Y、R3、Z、n、R4、A 和 B 如说明书中所定义,本发明还提供了制备它们的工艺、含有它们的药物组合物以及它们在治疗中的用途。